Elevated liver transaminases and their association with metabolic syndrome in type 2 diabetic patients attending tertiary care hospital of Nepal

References

• Ko SH, Baeg MK, Han KD, et al. Increased liver markers are associated with higher risk of type 2 diabetes. World J Gastroenterol. 2015;21:7478–7487.
   Web of Science ®Google Scholar
• Coban E, Kucuktag S, Basyigit S. Platelet activation in subjects with impaired glucose tolerance. Platelets. 2007;18:591–594.
   PubMed Web of Science ®Google Scholar
• Akinsegun A, Olusola DA, Sarah J-O, et al. Mean platelet volume and platelet counts in type 2 diabetes: mellitus on treatment and non-diabetic mellitus controls in Lagos, Nigeria. Pan Afr Med J. 2014;18(42):3651.
   Google Scholar
• Hu FB. Globalization of diabetes. Diabetes Care. 2011;34:1249–1257.
   PubMed Web of Science ®Google Scholar
• Al-Jameil N, Khan FA, Arjumand S, et al. Associated liver enzymes with hyperlipidemic profile in type 2 diabetes patients. Int J ClinPathol. 2014;7:4345–4349.
   Web of Science ®Google Scholar
• Music M, Dervisevic A, Pepic E, et al. Metabolic syndrome and serum liver enzymes level at patients with type 2 diabetes mellitus. Med Arch. 2015;69:251–255.
   PubMedGoogle Scholar
• Alberti G, Zimmet P, Shaw J. IDF epidemiology task force consensus group. The Metabolic Syndrome: a New World Wide Definition. Lancet. 2005;366:1059–1062.
   Google Scholar
• Paschos P, Paletas K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia. 2009;13:9.
   PubMed Web of Science ®Google Scholar
• Grundy S, Becker D, Clark L, et al. Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Circulation. 2002;106:3143–3421.
   PubMed Web of Science ®Google Scholar
• Pokharel DR, Khadka D, Sigdel M, et al. Prevalence of metabolic syndrome in Nepalese type 2 diabetic patients according to WHO, NCEP ATP III, IDF and harmonized criteria. J Diabetes MetabDisord. 2014;13:104.
   Google Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome. A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120:1640–1645.
   PubMed Web of Science ®Google Scholar
• Tan C-E, Ma S, Wai D, et al. Can we apply the national cholesterol education program adult treatment panel definition of the metabolic syndrome to Asians? Diabetes Care. 2004;27:1182–1186.
   PubMed Web of Science ®Google Scholar
• Fraser A, Harris R, Sattar N, et al. Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British women’s heart and health study and meta-analysis. Diabetes Care. 2009;32:741–750.
   PubMed Web of Science ®Google Scholar
• Neukam K, Bagwani S, Rodger A, et al. High prevalence of non-alcoholic fatty liver disease (NAFLD) among Gujarati Indians in North London: a population based study. ClinLipidol. 2017;12:33–39.
   Google Scholar
• Villegas R, Xiang Y-B, Elasy T, et al. Liver enzymes, type 2 diabetes, and metabolic syndrome in middle-aged, urban Chinese. men.MetabSyndrRelatDisord. 2011;9:305–311.
   Google Scholar
• Sharma SK, Ghimire A, Radhakrishnan J, et al. Prevalence of hypertension, obesity, diabetes, and metabolic syndrome in Nepal. Int J Hypertens. 2011;2011:821971.
   Google Scholar
• Thanpari C, Yadav N, Thakelmayum R. Status of antioxidant and liver function in type-2 diabetic patients attending Nepalgunj medical college. Bali Med J. 2013;2:1–4.
   Google Scholar
• Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2:231–237.
   PubMed Web of Science ®Google Scholar
• Harris EH. Elevated liver function tests in type 2 diabetes. ClinDiabetes. 2005;23:115–119.
   Google Scholar
• Forlani G, Di Bonito P, Mannucci E, et al. Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome. J Endocrinol Invest. 2008;31:146–152.
   PubMed Web of Science ®Google Scholar
• Judi L, Toukan A, Khader Y, et al. Prevalence of elevated hepatic transaminases among Jordanian patients with type 2 diabetes mellitus. Ann Saudi Med. 2010;30:25–32.
   PubMed Web of Science ®Google Scholar
• Atiba AS, Oparinde DP, Babatunde OA, et al. Liver enzymes and lipid profile among type 2 diabetic patients in Osogbo, Nigeria. Greener JMed Sci. 2013;3:174–178.
   Google Scholar
• Bora K, Borah M, Chutia H, et al. Presence of concurrent derangements of liver function tests in type 2 diabetes and their relationship with glycemic status: A retrospective observational study from Meghalaya. J Lab Physicians. 2016;8:30–35.
   Google Scholar
• Balogun W, Adeleye J, Akinlade K, et al. Frequent occurrence of high gamma-glutamyl transferase and alanine amino transferase among Nigerian patients with type 2 diabetes. Afr J Med Med Sci. 2008;37:177–183.
   Google Scholar
• Ni H, Soe HHK, Htet A. Determinants of abnormal liver function tests in diabetes patients in Myanmar. Int J Diabetes Res. 2012;1:36–41.
   Google Scholar
• Prabhudeva N, Pasha G, Mounika K. Hepatic dysfunction in diabetes mellitus: biochemical and ultrasonological study. J AcadInd Res. 2014;3:164–167.
   Google Scholar
• S KS, Sapkota S. Prevalence of metabolic syndrome in type 2 diabetes mellitus patients using NCEP/ATP III and IDF criteria in Nepal. Nepal J Med Sci. 2012;1:79–83.
   Google Scholar
• Tan MC NO T, Wong TW, Joseph A, et al. Prevalence of metabolic syndrome in type 2 diabetic patients: a comparative study using WHO, NCEP ATP III, IDF and Harmonized definitions. Health. 2013;5:1689–1696.
   Google Scholar
• de Simone G, Devereux RB, Chinali M, et al. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the strong heart study. Diabetes Care. 2007;30:1851–1856.
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84.
   PubMed Web of Science ®Google Scholar
• Rector RS, Thyfault JP, Wei Y, et al. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World JGastroenterol. 2008;14:185–192.
   PubMed Web of Science ®Google Scholar
• Uchil D, Pipalia D, Chawla M, et al. Non-alcoholic fatty liver disease (NAFLD)-the hepatic component of metabolic syndrome. J Assoc Physicians India. 2009;57:201–204.
   Google Scholar
• Esteghamati A, Jamali A, Khalilzadeh O, et al. Metabolic syndrome is linked to a mild elevation in liver aminotransferases in diabetic patients with undetectable non-alcoholic fatty liver disease by ultrasound. DiabetolMetabSyndr. 2010;2:65.
   Google Scholar
• Chen S, Guo X, Yu S, et al. Metabolic syndrome and serum liver enzymes in the general chinese population. Int J Environ Res Public Health. 2016;13:368.
   Web of Science ®Google Scholar
• Belkacemi L, Belalia M. Cross-sectional pilot study about the liver enzymes profile in type 2 diabetic patients from an Algerian west region: wilaya of Mostaganem. Diabetol MetabSyndrClin Res Rev. 2016;10:S147–S50.
   Google Scholar
• Nilssen O, Forde OH, Brenn T. Distribution of population determinants of gamma-glutamyl transferase. Am J Epidemiol. 1990;132:318–326.
   PubMed Web of Science ®Google Scholar
• Nakanishi N, Suzuki K, Tatara K. Serum γ-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care. 2004;27:1427–1432.
   PubMed Web of Science ®Google Scholar
• Wannamethee SG, Shaper AG, Lennon L, et al. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care. 2005;28:2913–2918.
   PubMed Web of Science ®Google Scholar
• Onat A, Can G, Çiçek G, et al. Serum γ‐glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease. Obesity. 2012;20:842–848.
   PubMed Web of Science ®Google Scholar
• Perez-Martinez P, Mikhailidis DP, Athyros VG, et al. Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation. Nutr Rev. 2017;75:307–326.
   PubMed Web of Science ®Google Scholar